GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (LSE:OBD) » Definitions » YoY EPS Growth

Oxford BioDynamics (LSE:OBD) YoY EPS Growth : 46.34% (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Oxford BioDynamics YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Oxford BioDynamics's YoY EPS Growth for the quarter that ended in Sep. 2024 was 46.34%.

Oxford BioDynamics's Earnings per Share (Diluted) for the six months ended in Sep. 2024 was £-0.02.


Oxford BioDynamics YoY EPS Growth Historical Data

The historical data trend for Oxford BioDynamics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics YoY EPS Growth Chart

Oxford BioDynamics Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -56.67 -53.19 6.94 -8.96 38.36

Oxford BioDynamics Semi-Annual Data
Sep14 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.56 -10.34 -7.89 28.13 46.34

Oxford BioDynamics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Oxford BioDynamics's YoY EPS Growth for the fiscal year that ended in Sep. 2024 is calculated as:

YoY EPS Growth (A: Sep. 2024 )
=(Earnings per Share (Diluted) (A: Sep. 2024 )-Earnings per Share (Diluted) (A: Sep. 2023 ))/ | Earnings per Share (Diluted) (A: Sep. 2023 ) |
=(-0.045--0.073)/ | -0.073 |
=38.36 %

Oxford BioDynamics's YoY EPS Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY EPS Growth (Q: Sep. 2024 )
=(Earnings per Share (Diluted) (Q: Sep. 2024 )-Earnings per Share (Diluted) (Q: Sep. 2023 )) / | Earnings per Share (Diluted) (Q: Sep. 2023 )) |
=(-0.022--0.041)/ | -0.041 |
=46.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford BioDynamics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford BioDynamics Business Description

Traded in Other Exchanges
Address
John Smith Drive, 3140 Rowan Place, ARC Oxford, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company engaged in developing and commercializing precision clinical diagnostic tests for life-changing diseases. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The tests are based on the company's proprietary 3D genomic biomarker platform, EpiSwitch which enables screening, evaluation, validation, and monitoring of biomarkers. In addition, the company offers, EpiSwitch Explorer Array Kit for 3D genome profiling. It is also developing new tests in the areas of oncology, neurology, inflammation, hepatology, and animal health. Geographically, it derives key revenue from the United States of America.

Oxford BioDynamics Headlines

No Headlines